{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,28]],"date-time":"2026-02-28T15:27:46Z","timestamp":1772292466227,"version":"3.50.1"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2023,7,21]],"date-time":"2023-07-21T00:00:00Z","timestamp":1689897600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,7,21]],"date-time":"2023-07-21T00:00:00Z","timestamp":1689897600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Dig Dis Sci"],"published-print":{"date-parts":[[2023,9]]},"DOI":"10.1007\/s10620-023-08031-y","type":"journal-article","created":{"date-parts":[[2023,7,21]],"date-time":"2023-07-21T13:01:47Z","timestamp":1689944507000},"page":"3801-3809","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["A Machine Learning Method to Identify the Risk Factors for Liver Fibrosis Progression in Nonalcoholic Steatohepatitis"],"prefix":"10.1007","volume":"68","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9794-7449","authenticated-orcid":false,"given":"Miguel","family":"Su\u00e1rez","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raquel","family":"Mart\u00ednez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ana Mar\u00eda","family":"Torres","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Beatriz","family":"Torres","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jorge","family":"Mateo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,7,21]]},"reference":[{"key":"8031_CR1","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1002\/hep.28431","volume":"64","author":"ZM Younossi","year":"2016","unstructured":"Younossi ZM, Koenig AB, Abdelatif D, Fazel Y, Henry L, Wymer M. Global epidemiology of nonalcoholic fatty liver disease: meta-analytic assessment of prevalence, incidence, and outcomes. Hepatology 2016;64:73\u201384.","journal-title":"Hepatology"},{"key":"8031_CR2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhepr.2021.100234","volume":"3","author":"JV Lazarus","year":"2021","unstructured":"Lazarus JV, Palayew A, Carrieri P et al. European \u2018NAFLD Preparedness Index\u2019: is Europe ready to meet the challenge of fatty liver disease? JHEP Rep. 2021;3:100234.","journal-title":"JHEP Rep."},{"key":"8031_CR3","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2023.04.036","author":"VW-S Wong","year":"2023","unstructured":"Wong VW-S, Ekstedt M, Wong GLH, Hagstr\u00f6m H. Changing epidemiology, global trends and implications for outcomes of NAFLD. J. Hepatol. 2023. https:\/\/doi.org\/10.1016\/j.jhep.2023.04.036.","journal-title":"J. Hepatol."},{"key":"8031_CR4","doi-asserted-by":"publisher","first-page":"2212","DOI":"10.1016\/S0140-6736(20)32511-3","volume":"397","author":"EE Powell","year":"2021","unstructured":"Powell EE, Wong VW-S, Rinella M. Non-alcoholic fatty liver disease. Lancet 2021;397:2212\u20132224.","journal-title":"Lancet"},{"key":"8031_CR5","doi-asserted-by":"publisher","DOI":"10.1097\/HEP.0000000000000323","volume":"77","author":"ME Rinella","year":"2023","unstructured":"Rinella ME, Neuschwander-Tetri BA, Siddiqui MS et al. AASLD practice guidance on the clinical assessment and management of nonalcoholic fatty liver disease. Hepatology 2023;77:101097.","journal-title":"Hepatology"},{"key":"8031_CR6","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1002\/ueg2.12150","volume":"9","author":"A-M van Dijk","year":"2021","unstructured":"van Dijk A-M, Schattenberg JM, Holleboom AG, Tushuizen ME. Referral care paths for non-alcoholic fatty liver disease: gearing up for an ever more prevalent and severe liver disease. United Eur. Gastroenterol. J. 2021;9:903\u2013909.","journal-title":"United Eur. Gastroenterol. J."},{"key":"8031_CR7","doi-asserted-by":"publisher","first-page":"46","DOI":"10.3390\/biomedicines10010046","volume":"10","author":"A Santos-Laso","year":"2021","unstructured":"Santos-Laso A, Guti\u00e9rrez-Larra\u00f1aga M, Alonso-Pe\u00f1a M et al. Pathophysiological mechanisms in non-alcoholic fatty liver disease: from drivers to targets. Biomedicines 2021;10:46.","journal-title":"Biomedicines"},{"key":"8031_CR8","doi-asserted-by":"publisher","first-page":"1080","DOI":"10.1016\/j.metabol.2015.11.008","volume":"65","author":"GT Brown","year":"2016","unstructured":"Brown GT, Kleiner DE. Histopathology of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis. Metabolism 2016;65:1080\u20131086.","journal-title":"Metabolism"},{"key":"8031_CR9","doi-asserted-by":"publisher","first-page":"1476","DOI":"10.1016\/j.jhep.2021.08.012","volume":"75","author":"GN Ioannou","year":"2021","unstructured":"Ioannou GN. Epidemiology and risk-stratification of NAFLD-associated HCC. J. Hepatol. 2021;75:1476\u20131484.","journal-title":"J. Hepatol."},{"key":"8031_CR10","doi-asserted-by":"publisher","first-page":"1999","DOI":"10.1053\/j.gastro.2019.11.312","volume":"158","author":"M Eslam","year":"2020","unstructured":"Eslam M, Sanyal AJ, George J et al. MAFLD: a consensus driven proposed nomenclature for metabolic associated fatty liver disease. Gastroenterology 2020;158:1999-2014.e1.","journal-title":"Gastroenterology"},{"key":"8031_CR11","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1016\/S2213-8587(22)00003-1","volume":"10","author":"N Stefan","year":"2022","unstructured":"Stefan N, Cusi K. A global view of the interplay between non-alcoholic fatty liver disease and diabetes. Lancet Diabetes Endocrinol. 2022;10:284.","journal-title":"Lancet Diabetes Endocrinol."},{"key":"8031_CR12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s40261-022-01142-w","volume":"42","author":"J Ampuero","year":"2022","unstructured":"Ampuero J. General overview about the current management of nonalcoholic fatty liver disease. Clin. Drug Investig. 2022;42:1\u20137.","journal-title":"Clin. Drug Investig."},{"key":"8031_CR13","doi-asserted-by":"publisher","first-page":"2537","DOI":"10.1016\/j.cell.2021.04.015","volume":"184","author":"R Loomba","year":"2021","unstructured":"Loomba R, Friedman SL, Shulman GI. Mechanisms and disease consequences of nonalcoholic fatty liver disease. Cell 2021;184:2537\u20132564.","journal-title":"Cell"},{"key":"8031_CR14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s43856-022-00228-y","volume":"3","author":"JM Schattenberg","year":"2023","unstructured":"Schattenberg JM, Allen AM, Jarvis H et al. A multistakeholder approach to innovations in NAFLD care. Commun. Med. 2023;3:1.","journal-title":"Commun. Med."},{"key":"8031_CR15","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2021.711484","author":"S Ciardullo","year":"2021","unstructured":"Ciardullo S, Cannistraci R, Mazzetti S, Mortara A, Perseghin G. Nonalcoholic fatty liver disease, liver fibrosis and cardiovascular disease in the adult US population. Front. Endocrinol. 2021. https:\/\/doi.org\/10.3389\/fendo.2021.711484.","journal-title":"Front. Endocrinol."},{"key":"8031_CR16","doi-asserted-by":"publisher","first-page":"968","DOI":"10.3390\/jcm11040968","volume":"11","author":"A Mantovani","year":"2022","unstructured":"Mantovani A, Dalbeni A, Beatrice G, Cappelli D, Gomez-Peralta F. Non-alcoholic fatty liver disease and risk of macro and microvascular complications in patients with type 2 diabetes. J. Clin. Med. 2022;11:968.","journal-title":"J. Clin. Med."},{"key":"8031_CR17","doi-asserted-by":"publisher","first-page":"1229","DOI":"10.1016\/j.jhep.2019.08.018","volume":"71","author":"AM Allen","year":"2019","unstructured":"Allen AM, Hicks SB, Mara KC, Larson JJ, Therneau TM. The risk of incident extrahepatic cancers is higher in non-alcoholic fatty liver disease than obesity: a longitudinal cohort study. J. Hepatol. 2019;71:1229\u20131236.","journal-title":"J. Hepatol."},{"key":"8031_CR18","doi-asserted-by":"publisher","first-page":"1985","DOI":"10.1053\/j.gastro.2020.07.050","volume":"159","author":"M Noureddin","year":"2020","unstructured":"Noureddin M, Jones C, Alkhouri N et al. Screening for non-alcoholic fatty liver disease in persons with type 2 diabetes in the United States is cost-effective: a comprehensive cost-utility analysis. Gastroenterology 2020;159:1985\u20131987.","journal-title":"Gastroenterology"},{"key":"8031_CR19","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1038\/s41575-020-00406-0","volume":"18","author":"MF Abdelmalek","year":"2021","unstructured":"Abdelmalek MF. Nonalcoholic fatty liver disease: another leap forward. Nat. Rev. Gastroenterol. Hepatol. 2021;18:85\u201386.","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"8031_CR20","doi-asserted-by":"publisher","first-page":"1200","DOI":"10.1038\/s41401-022-00874-x","volume":"43","author":"XF Tong","year":"2022","unstructured":"Tong XF, Wang QY, Zhao XY et al. Histological assessment based on liver biopsy: the value and challenges in NASH drug development. Acta Pharmacol. Sin. 2022;43:1200\u20131209.","journal-title":"Acta Pharmacol. Sin."},{"key":"8031_CR21","doi-asserted-by":"crossref","unstructured":"Romero-G\u00f3mez M. Esteatohepatitis no alcoh\u00f3lica. Medicina Cl\u00ednica; 2022.","DOI":"10.1016\/j.medcli.2022.06.017"},{"key":"8031_CR22","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1111\/liv.14669","volume":"41","author":"J Lee","year":"2021","unstructured":"Lee J, Vali Y, Boursier J et al. Prognostic accuracy of FIB-4, NAFLD fibrosis score and APRI for NAFLD-related events: a systematic review. Liver Int. 2021;41:261\u2013270.","journal-title":"Liver Int."},{"key":"8031_CR23","doi-asserted-by":"crossref","unstructured":"M\u00e9ndez-S\u00e1nchez N, M\u00e9ndez-S\u00e1nchez N, Cerda-Reyes E et al. Dyslipidemia as a risk factor for liver fibrosis progression in a multicentric population with non-alcoholic steatohepatitis. Harvard Dataverse; 2020.","DOI":"10.12688\/f1000research.21918.1"},{"key":"8031_CR24","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1038\/nrgastro.2017.109","volume":"15","author":"Z Younossi","year":"2018","unstructured":"Younossi Z, Anstee QM, Marietti M et al. Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention. Nat. Rev. Gastroenterol. Hepatol. 2018;15:11\u201320.","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"8031_CR25","doi-asserted-by":"publisher","first-page":"1313","DOI":"10.1002\/hep.20701","volume":"41","author":"DE Kleiner","year":"2005","unstructured":"Kleiner DE, Brunt EM, Van Natta M, Behling C, Contos MJ, Cummings OW. Nonalcoholic steatohepatitis clinical research network. Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology 2005;41:1313\u20131321.","journal-title":"Hepatology"},{"key":"8031_CR26","doi-asserted-by":"crossref","unstructured":"Detection NCEPEPo, Adults ToHBCi. Third report of the National Cholesterol Education Program (NCEP) Expert Panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). The Program; 2002.","DOI":"10.1001\/jama.285.19.2486"},{"key":"8031_CR27","doi-asserted-by":"publisher","first-page":"1345","DOI":"10.1109\/TNNLS.2016.2540719","volume":"28","author":"C Chen","year":"2016","unstructured":"Chen C, Dong D, Qi B, Petersen IR, Rabitz H. Quantum ensemble classification: a sampling-based learning control approach. IEEE Trans. Neural Netw. Learn. Syst. 2016;28:1345\u20131359.","journal-title":"IEEE Trans. Neural Netw. Learn. Syst."},{"key":"8031_CR28","doi-asserted-by":"publisher","first-page":"175248","DOI":"10.1109\/ACCESS.2019.2957367","volume":"7","author":"W Chang","year":"2019","unstructured":"Chang W, Liu Y, Wu X, Xiao Y, Zhou S, Cao W. A new hybrid XGBSVM model: application for hypertensive heart disease. IEEE Access 2019;7:175248\u2013175258.","journal-title":"IEEE Access"},{"key":"8031_CR29","doi-asserted-by":"publisher","first-page":"1203","DOI":"10.1049\/iet-rsn.2016.0632","volume":"11","author":"W Chen","year":"2017","unstructured":"Chen W, Fu K, Zuo J, Zheng X, Huang T, Ren W. Radar emitter classification for large data set based on weighted-xgboost. IET Radar Sonar Navig. 2017;11:1203\u20131207.","journal-title":"IET Radar Sonar Navig."},{"key":"8031_CR30","doi-asserted-by":"publisher","first-page":"118931","DOI":"10.1109\/ACCESS.2019.2933437","volume":"7","author":"S Yu","year":"2019","unstructured":"Yu S, Li X, Zhang X, Wang H. The OCS-SVM: an objective-cost-sensitive SVM with sample-based misclassification cost invariance. IEEE Access 2019;7:118931\u2013118942.","journal-title":"IEEE Access"},{"key":"8031_CR31","doi-asserted-by":"publisher","first-page":"5548","DOI":"10.1109\/ACCESS.2017.2788700","volume":"6","author":"R Rivera-Lopez","year":"2018","unstructured":"Rivera-Lopez R, Canul-Reich J. Construction of near-optimal axis-parallel decision trees using a differential-evolution-based approach. IEEE Access 2018;6:5548\u20135563.","journal-title":"IEEE Access"},{"key":"8031_CR32","doi-asserted-by":"publisher","first-page":"7716","DOI":"10.1109\/ACCESS.2016.2585661","volume":"4","author":"A Sharmila","year":"2016","unstructured":"Sharmila A, Geethanjali P. DWT based detection of epileptic seizure from EEG signals using naive Bayes and k-NN classifiers. IEEE Access 2016;4:7716\u20137727.","journal-title":"IEEE Access"},{"key":"8031_CR33","doi-asserted-by":"publisher","first-page":"28808","DOI":"10.1109\/ACCESS.2019.2955754","volume":"8","author":"W Xing","year":"2019","unstructured":"Xing W, Bei Y. Medical health big data classification based on KNN classification algorithm. IEEE Access 2019;8:28808\u201328819.","journal-title":"IEEE Access"},{"key":"8031_CR34","volume-title":"Data mining: concepts and techniques","author":"H Jiawei","year":"2012","unstructured":"Jiawei H, Micheline K, Jian P. Data mining: concepts and techniques, 3rd edn. Burlington: Morgan kaufmann; 2012.","edition":"3"},{"key":"8031_CR35","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1159\/000443344","volume":"9","author":"E Easl","year":"2016","unstructured":"Easl E. EASO clinical practice guidelines for the management of non-alcoholic fatty liver disease. Obes. Facts 2016;9:65\u201390.","journal-title":"Obes. Facts"},{"key":"8031_CR36","doi-asserted-by":"crossref","unstructured":"Basu R, Noureddin M, Clark JM. Nonalcoholic fatty liver disease: review of Management for Primary Care Providers. In Mayo Clinic Proceedings. Elsevier; 2022.","DOI":"10.1016\/j.mayocp.2022.04.005"},{"key":"8031_CR37","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1016\/j.eprac.2022.03.010","volume":"28","author":"K Cusi","year":"2022","unstructured":"Cusi K, Isaacs S, Barb D et al. American Association of Clinical Endocrinology clinical practice guideline for the diagnosis and management of nonalcoholic fatty liver disease in primary care and endocrinology clinical settings: co-sponsored by the American Association for the Study of Liver Diseases (AASLD). Endocr. Pract. 2022;28:528\u2013562.","journal-title":"Endocr. Pract."},{"key":"8031_CR38","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhepr.2021.100322","volume":"3","author":"SM Francque","year":"2021","unstructured":"Francque SM, Marchesini G, Kautz A et al. Non-alcoholic fatty liver disease: a patient guideline. JHEP Rep. 2021;3:100322.","journal-title":"JHEP Rep."},{"key":"8031_CR39","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1038\/s41575-021-00523-4","volume":"19","author":"JV Lazarus","year":"2022","unstructured":"Lazarus JV, Mark HE, Anstee QM et al. Advancing the global public health agenda for NAFLD: a consensus statement. Nat. Rev. Gastroenterol. Hepatol. 2022;19:60\u201378.","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"8031_CR40","doi-asserted-by":"publisher","DOI":"10.1016\/j.molmet.2020.101092","volume":"42","author":"A Deprince","year":"2020","unstructured":"Deprince A, Haas JT, Staels B. Dysregulated lipid metabolism links NAFLD to cardiovascular disease. Mol. Metab. 2020;42:101092.","journal-title":"Mol. Metab."},{"key":"8031_CR41","doi-asserted-by":"publisher","first-page":"1547","DOI":"10.1056\/NEJMoa2036205","volume":"385","author":"SM Francque","year":"2021","unstructured":"Francque SM, Bedossa P, Ratziu V et al. A randomized, controlled trial of the pan-PPAR agonist lanifibranor in NASH. N. Engl. J. Med. 2021;385:1547\u20131558.","journal-title":"N. Engl. J. Med."},{"key":"8031_CR42","doi-asserted-by":"publisher","first-page":"1382","DOI":"10.1136\/gutjnl-2020-321299","volume":"69","author":"J Neuberger","year":"2020","unstructured":"Neuberger J, Patel J, Caldwell H et al. Guidelines on the use of liver biopsy in clinical practice from the British Society of Gastroenterology, the Royal College of Radiologists and the Royal College of Pathology. Gut 2020;69:1382\u20131403.","journal-title":"Gut"},{"key":"8031_CR43","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1111\/apt.17346","volume":"57","author":"Z Younossi","year":"2023","unstructured":"Younossi Z, Alkhouri N, Cusi K et al. A practical use of noninvasive tests in clinical practice to identify high-risk patients with nonalcoholic steatohepatitis. Aliment. Pharmacol. Ther. 2023;57:304\u2013312.","journal-title":"Aliment. Pharmacol. Ther."},{"key":"8031_CR44","unstructured":"Kanter Coronel I. Magnitud del sobrepeso y la obesidad en M\u00e9xico: un cambio de estrategia para su erradicaci\u00f3n. 2021."},{"key":"8031_CR45","doi-asserted-by":"publisher","first-page":"50","DOI":"10.21149\/10752","volume":"62","author":"A Basto-Abreu","year":"2022","unstructured":"Basto-Abreu A, Barrientos-Guti\u00e9rrez T, Rojas-Mart\u00ednez R et al. Prevalencia de diabetes y descontrol gluc\u00e9mico en M\u00e9xico: resultados de la Ensanut 2016. Salud P\u00fablica de M\u00e9xico 2022;62:50\u201359.","journal-title":"Salud P\u00fablica de M\u00e9xico"},{"key":"8031_CR46","doi-asserted-by":"publisher","first-page":"888","DOI":"10.21149\/10574","volume":"61","author":"I Campos-Nonato","year":"2019","unstructured":"Campos-Nonato I, Hern\u00e1ndez-Barrera L, Flores-Coria A, G\u00f3mez-\u00c1lvarez E, Barquera S. Prevalencia, diagn\u00f3stico y control de hipertensi\u00f3n arterial en adultos mexicanos en condici\u00f3n de vulnerabilidad. Resultados de la Ensanut 100k. Salud P\u00fablica de M\u00e9xico 2019;61:888\u2013897.","journal-title":"Salud P\u00fablica de M\u00e9xico"},{"key":"8031_CR47","doi-asserted-by":"publisher","first-page":"1246","DOI":"10.1002\/hep.32510","volume":"76","author":"CP Oliveira","year":"2022","unstructured":"Oliveira CP. Should PNPLA3 polymorphism be performed in clinical practice in patients with NAFLD to predict the risk of disease progression? Hepatology 2022;76:1246\u20131247.","journal-title":"Hepatology"},{"key":"8031_CR48","first-page":"3133","volume":"15","author":"M Fern\u00e1ndez-Delgado","year":"2014","unstructured":"Fern\u00e1ndez-Delgado M, Cernadas E, Barro S, Amorim D. Do we need hundreds of classifiers to solve real world classification problems? J. Mach. Learn. Res. 2014;15:3133\u20133181.","journal-title":"J. Mach. Learn. Res."},{"key":"8031_CR49","unstructured":"Han J, Kamber M, Pei J. Data mining concepts and techniques third edition. University of Illinois at Urbana-Champaign Micheline Kamber Jian Pei Simon Fraser University, 2012."}],"container-title":["Digestive Diseases and Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-023-08031-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10620-023-08031-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-023-08031-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,23]],"date-time":"2023-08-23T03:31:25Z","timestamp":1692761485000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10620-023-08031-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7,21]]},"references-count":49,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2023,9]]}},"alternative-id":["8031"],"URL":"https:\/\/doi.org\/10.1007\/s10620-023-08031-y","relation":{},"ISSN":["0163-2116","1573-2568"],"issn-type":[{"value":"0163-2116","type":"print"},{"value":"1573-2568","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,7,21]]},"assertion":[{"value":"9 March 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 June 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 July 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"None to declare by the authors.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}